WASHINGTON, DC – Congressman Brian Fitzpatrick (PA-1), along with Congressmen Neal Dunn, M.D. (FL-02) and Darren Soto (FL-09), introduced the Joe Fiandra Access to Home Infusion Act of 2025, bipartisan legislation to expand Medicare coverage of home infusion therapies by ensuring that external infusion pumps and certain non-self-administrable drugs are covered as Durable Medical Equipment (DME).
The bill is named in honor of Joe Fiandra, a proud Army veteran from Warrington and constituent of Pennsylvania’s First District, who passed away in 2022 after a courageous battle with amyloidosis. Joe’s struggle to access the treatments he needed inspired this reform, which seeks to ensure that no family is ever forced to confront the same barriers.
“Joe Fiandra’s story is one of service, devotion, and courage. He was a hero veteran who served our nation with honor, a husband devoted to his family, and a man of extraordinary strength. But his fight revealed barriers in our health care system that no patient should ever have endure,” said Congressman Fitzpatrick. “That is why I worked with Joe’s family, the amyloidosis community, and colleagues on both sides of the aisle to turn his struggle into meaningful reform. This bill will ensure Medicare beneficiaries can receive life-saving infusion drugs and equipment at home—surrounded by loved ones, with dignity and compassion. By carrying Joe’s name forward in this legislation, we honor his legacy of service and strength, and deliver hope and relief to families across the nation.”
"Joe faced his illness with the same courage that defined his life, but the barriers to accessing his treatments made an already difficult battle even harder. This bill ensures that no family will have to endure those same struggles. I am deeply grateful to Congressman Fitzpatrick for standing with our family from the beginning, listening to our story, and turning it into action. Having this legislation bear Joe’s name is both an honor and a comfort—it means that his fight will spare other families from suffering, and his life will continue to make a difference for years to come,” said Helen Fiandra.
“I am proud to join this bipartisan effort to expand access to home infusion treatments and ensure they are covered under Medicaid benefits,” said Congresssman Soto. “Individuals struggling with serious illnesses do not need more roadblocks—they need solutions. I hope to see our bill move forward quickly so those in need can receive the care they need.”
“Home infusion services are vital to the health of American seniors,” said Congressman Dunn. “Allowing comprehensive Medicare coverage for at-home treatments will save the program money and allow families to care for their loved ones while ensuring that seniors can remain in the comfort of their own homes.”
In 2020, the Centers for Medicare and Medicaid Services proposed clarifying that the Home Infusion Therapy Benefit, created under the 21st Century Cures Act, was not limited to drugs that are self-administered but should also include infusion drugs requiring professional oversight. The rule was never finalized, leaving patients without coverage for critical therapies.
The Joe Fiandra Access to Home Infusion Act of 2025 corrects this gap by amending the Social Security Act to explicitly cover external infusion pumps and associated infusion drugs as DME if:
- The FDA-approved prescribing information requires administration by or under the supervision of a health care professional.
- The drug is administered in the home by a qualified supplier.
- The therapy is prescribed at least 12 times annually, or at infusion rates requiring the use of an external pump.
The legislation also requires the Department of Health and Human Services to notify patients of cost-sharing obligations for home infusion therapy compared to other care settings.
The bill is supported by the Amyloidosis Support Group and previously advanced out of the House Ways and Means Committee in the 118th Congress with bipartisan backing.
###